Modeling diabetic epitheliopathy using 3D-Organotypic corneal epithelium

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Diabetic Complications

Background:

• Diabetic keratopathy (DK) affects over 50% of diabetic patients, linked to hyperglycemia-induced corneal changes.
• Current in vitro (2D) and animal models poorly replicate human corneal pathophysiology and raise ethical concerns.
• There is a need for advanced models to study DK effectively and reduce animal testing.

Purpose of the Study:

• To develop a novel 3D-organotypic air-liquid interface (ALI) model of diabetic epitheliopathy using human corneal epithelial cells (hCECs).
• To validate this model's ability to mimic key pathological features of diabetic corneal disease.
• To establish a more predictive and ethically sound platform for DK research and drug development.

Main Methods:

• Human corneal epithelial cells (hCECs) were differentiated into 3D-organotypic ALI cultures.
• These 3D cultures were exposed to high-glucose conditions to simulate a diabetic environment.
• Molecular and cellular markers of inflammation and tissue damage were analyzed.

Main Results:

• The 3D-organotypic ALI model successfully replicated key features of diabetic epitheliopathy.
• Observed characteristics included epithelial defects and significant inflammation.
• Increased expression of key inflammatory markers (IL-1β, TNF-α, p-NF-kB) and matrix metalloproteinases (MMP-2, MMP-9) was noted.

Conclusions:

• The 3D-organotypic corneal epithelium model is a valuable tool for studying diabetic epitheliopathy.
• This model offers a more accurate representation of the disease compared to traditional methods.
• It provides a promising platform for drug screening and advancing precision medicine for diabetic eye complications.